Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

BCLI holding history

Brainstorm Cell Therapeutics Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCLI overviewAll 13F holders of BCLIFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of BCLI by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−54,582−100.0%Sold outHolders
Q2 202554,582$61.1K<0.1%−3,583−6.2%ReducedHolders
Q1 202558,165$73.3K<0.1%+5,664+10.8%AddedHolders
Q4 202452,501$119.2K<0.1%+6,980+15.3%AddedConverted for a 1-for-15 splitHolders
Q3 2024682,816$152.0K<0.1%+198,531+41.0%AddedHolders
Q2 2024484,285$164.0K<0.1%+127,244+35.6%AddedHolders
Q1 2024357,041$201.7K<0.1%00.0%UnchangedHolders
Q4 2023357,041$97.5K<0.1%+46,264+14.9%AddedHolders
Q3 2023310,777$62.2K<0.1%+35,071+12.7%AddedHolders
Q2 2023275,706$568.0K<0.1%00.0%UnchangedHolders
Q1 2023275,706$909.8K<0.1%+2,000+0.7%AddedHolders
Q4 2022273,706$448.0K<0.1%−2,930−1.1%ReducedHolders
Q3 2022276,636$1.22M<0.1%+727+0.3%AddedHolders
Q2 2022275,909$761.0K<0.1%−7,576−2.7%ReducedHolders
Q1 2022283,485$952.0K<0.1%+5,384+1.9%AddedHolders
Q4 2021278,101$1.11M<0.1%+2,351+0.9%AddedHolders
Q3 2021275,750$909.0K<0.1%+10,612+4.0%AddedHolders
Q2 2021265,138$1.01M<0.1%−213,120−44.6%ReducedHolders
Q1 2021478,258$1.83M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.